-
1
المؤلفون: Rahul Kashyap, Hemang Yadav, John C. O’Horo, Dan Reynolds, Lin Dou, Ognjen Gajic, Lindsey Wallace
المصدر: Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 4, Iss 2, Pp 176-182 (2020)مصطلحات موضوعية: Oseltamivir, medicine.medical_specialty, medicine.drug_class, 030204 cardiovascular system & hematology, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, PCR, polymerase chain reaction, Interquartile range, law, Internal medicine, medicine, In patient, 030212 general & internal medicine, IQR, interquartile range, lcsh:R5-920, Neuraminidase inhibitor, Proportional hazards model, business.industry, NAI, neuraminidase inhibitor, Hazard ratio, virus diseases, Retrospective cohort study, Intensive care unit, HR, hazard ratio, ICU, intensive care unit, chemistry, Original Article, business, lcsh:Medicine (General), LOS, length of stay
-
2
المؤلفون: Elena A. Govorkova, David S.C. Hui, Shibo Jiang, Jennifer L. McKimm-Breschkin, Nelson Lee, John H. Beigel
المصدر: Antiviral Research
مصطلحات موضوعية: TCID50, 50% tissue culture infectivity dose, 0301 basic medicine, HPAI, Highly pathogenic avian influenza, medicine.medical_specialty, viruses, RDB, randomized double blind, Favipiravir, Article, Virus, SARS-CoV, Severe acute respiratory syndrome corona virus, 03 medical and health sciences, PCT, Placebo controlled trial, Virology, ARDS, Acute respiratory distress syndrome, Medicine, Metapneumovirus, Intensive care medicine, Pharmacology, Vaccines, LPM, Live poultry markets, biology, NAI, neuraminidase inhibitor, business.industry, Public health, RSV, virus diseases, Nitazoxanide, Antivirals, AUC, Area under the curve, NA, neuraminidase, PRNT, plaque reduction neutralization titer, Influenza, CAP, Community acquired pneumonia, Clinical trial, 030104 developmental biology, Isirv-AVG, biology.protein, Respiratory virus, MN, microneutralization, MERS-CoV, Middle East respiratory syndrome corona virus, business, Neuraminidase, S/ARI, Severe/Acute respiratory infection, HA, hemagglutinin, medicine.drug
-
3
المؤلفون: Nikolaos G. Papadopoulos, Olympia Vangelatou, Paraskevi Xepapadaki, Nikolaos A. Kitsioulis, Spyridon Megremis, Peter W. West
المصدر: Megremis, S, Papadopoulos, N, Kitsioulis, N A, Vangelatou, O, West, P & Xepapadaki, P 2017, ' Promising approaches for treatment and prevention of viral respiratory illnesses ', Journal of Allergy and Clinical Immunology . https://doi.org/10.1016/j.jaci.2017.07.001
The Journal of Allergy and Clinical Immunologyمصطلحات موضوعية: 0301 basic medicine, SARS, Severe acute respiratory syndrome, Rhinovirus, natural products, respiratory syncytial virus, viruses, vRTI, Viral respiratory tract infection, medicine.disease_cause, SPM, Specialized proresolving lipid mediator, Viral Respiratory Tract Infection, vaccine, Immunology and Allergy, VLP, Virus-like particle, PIV, Parainfluenza Virus, Respiratory Tract Infections, Respiratory tract infections, biology, Neuraminidase inhibitor, Viral Vaccine, public health, Common cold, Orthomyxoviridae, antiviral, Respiratory Syncytial Viruses, 3. Good health, Virus Diseases, RSV, Respiratory syncytial virus, bronchiolitis, NAI, Neuraminidase inhibitor, Immunotherapy, TLR, Toll-like receptor, medicine.drug_class, ICAM-1, Intercellular adhesion molecule 1, Immunology, monoclonal, COPD, Chronic obstructive pulmonary disease, RTI, Respiratory tract infection, Mass Vaccination, Article, 03 medical and health sciences, medicine, Animals, Humans, IFV, Influenza virus, Viral Vaccines, medicine.disease, biology.organism_classification, common cold, Influenza, 030104 developmental biology, Bronchiolitis, HA, Hemagglutinin
وصف الملف: application/pdf